{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:44:51Z","timestamp":1787244291785,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,11]]},"DOI":"10.7759\/cureus.38886","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T12:00:43Z","timestamp":1683806443000},"source":"Crossref","is-referenced-by-count":4,"title":["Assessment of Fertility Outcomes Following Combined Clomiphene and Letrozole Versus Letrozole Therapy for the Treatment of Polycystic Ovarian Syndrome Subfertility"],"prefix":"10.7759","author":[{"given":"Priyanka","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avir","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish C","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Jaggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz R","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006, 91:4237-45. 10.1210\/jc.2006-0178","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:30:1:19","article-title":"The role of genes and environment in the etiology of PCOS","volume":"30","author":"Diamanti-Kandarakis E","year":"2006","unstructured":"Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine. 2006, 30:19-26. 10.1385\/ENDO:30:1:19","journal-title":"Endocrine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March WA","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010, 25:544-51. 10.1093\/humrep\/dep399","journal-title":"Hum Reprod"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag G","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016, 31:2841-55. 10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz R","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004, 89:2745-9. 10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate--end of an era? A mini-review","volume":"20","author":"Homburg R","year":"2005","unstructured":"Homburg R. Clomiphene citrate--end of an era? A mini-review. Hum Reprod. 2005, 20:2043-51. 10.1093\/humrep\/dei042","journal-title":"Hum Reprod"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)46033-4","article-title":"A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test","volume":"37","author":"Gysler M","year":"1982","unstructured":"Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril. 1982, 37:161-7. 10.1016\/s0015-0282(16)46033-4","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018, 33:1602-18. 10.1093\/humrep\/dey256","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/147323000603400109","article-title":"Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation","volume":"34","author":"Atay V","year":"2006","unstructured":"Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006, 34:73-6. 10.1177\/147323000603400109","journal-title":"J Int Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81.19-25. 10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq019","article-title":"WHO reference values for human semen","volume":"16","author":"Tocci A","year":"2010","unstructured":"Tocci A, Lucchini C. WHO reference values for human semen. Hum Reprod Update. 2010, 16:559; author reply 559. 10.1093\/humupd\/dmq019","journal-title":"Hum Reprod Update"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13375","article-title":"Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial","volume":"152","author":"Bansal S","year":"2021","unstructured":"Bansal S, Goyal M, Sharma C, Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial. Int J Gynaecol Obstet. 2021, 152:345-50. 10.1002\/ijgo.13375","journal-title":"Int J Gynaecol Obstet"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.4236\/ojog.2019.911149","article-title":"Simultaneous letrozole and clomiphene citrate versus letrozole alone in clomiphene citrate resistant polycystic ovary syndrome: a randomised controlled trial","volume":"9","author":"Ibrahem MA","year":"2019","unstructured":"Ibrahem MA. Simultaneous letrozole and clomiphene citrate versus letrozole alone in clomiphene citrate resistant polycystic ovary syndrome: a randomised controlled trial. Open J Obstet Gynecol. 2019, 9:1532-40.","journal-title":"Open J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia RB","year":"2019","unstructured":"Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019, 111:571-578.e1. 10.1016\/j.fertnstert.2018.11.030","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S50972","article-title":"Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome","volume":"7","author":"Hajishafiha M","year":"2013","unstructured":"Hajishafiha M, Dehghan M, Kiarang N, Sadegh-Asadi N, Shayegh SN, Ghasemi-Rad M. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome. Drug Des Devel Ther. 2013, 7:1427-31. 10.2147\/DDDT.S50972","journal-title":"Drug Des Devel Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154637-assessment-of-fertility-outcomes-following-combined-clomiphene-and-letrozole-versus-letrozole-therapy-for-the-treatment-of-polycystic-ovarian-syndrome-subfertility","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:00:21Z","timestamp":1707490821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154637-assessment-of-fertility-outcomes-following-combined-clomiphene-and-letrozole-versus-letrozole-therapy-for-the-treatment-of-polycystic-ovarian-syndrome-subfertility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.38886","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}